More than four years after the COVID-19 pandemic caused the world to come to a standstill, lessons in pandemic response are still being learned. What we know: the global pandemic disproportionately ...
Universal, stage-agnostic molecular profiling in NSCLC is increasingly necessary, as under-testing (including absent RNA fusion panels) can misdirect immunotherapy use in EGFR/ALK-altered disease.
On National HIV Testing Day, getting tested remains a gateway to prevention and treatment, but improving access alone is not enough. Expanding access to PrEP, PEP, pharmacists, long-acting therapies, ...
STAMFORD, Conn.--(BUSINESS WIRE)-- GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced Biogen (Nasdaq: BIIB), Praxis Precision Medicines ...
Diagnostic yields in rare disease have risen markedly with genomic testing, with many patients experiencing downstream clinical benefit through improved decision-making, prognosis clarification, and ...
Analysis of Tumor Microenvironmental Features Between Primary and Synchronous Liver Metastases From Patients With Colorectal Cancers Using a Deep Learning Algorithm We identified a cohort of 1,201 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results